GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Instituto Rosenbusch SA (BUE:ROSE) » Definitions » 3-Year FCF Growth Rate

Instituto Rosenbusch (BUE:ROSE) 3-Year FCF Growth Rate : 16.50% (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Instituto Rosenbusch 3-Year FCF Growth Rate?

Instituto Rosenbusch's Free Cash Flow per Share for the three months ended in Mar. 2024 was ARS12.80.

During the past 12 months, Instituto Rosenbusch's average Free Cash Flow per Share Growth Rate was 40.20% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 16.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Instituto Rosenbusch was 477.40% per year. The lowest was -72.90% per year. And the median was 4.80% per year.


Competitive Comparison of Instituto Rosenbusch's 3-Year FCF Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Instituto Rosenbusch's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Instituto Rosenbusch's 3-Year FCF Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Instituto Rosenbusch's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Instituto Rosenbusch's 3-Year FCF Growth Rate falls into.



Instituto Rosenbusch 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


Instituto Rosenbusch  (BUE:ROSE) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


Instituto Rosenbusch 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Instituto Rosenbusch's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Instituto Rosenbusch (BUE:ROSE) Business Description

Traded in Other Exchanges
N/A
Address
Hipolito Yrigoyen 1628, Buenos Aires, ARG, C1089AAF
Instituto Rosenbusch SA is a pharmaceutical company based in Argentina. The company is engaged in the processing and industrialization of biological, chemical, pharmaceutical products of any kind, nature or destination, preferably for veterinary use or intended to combat pests and diseases of the agricultural exploitation. The company has line of products such as Biologicals and pharmaceuticals. Biologicals offer Campy 3, Cultivac 6M and Bovine Antibrucelosis. Pharmaceuticals offer Diclosan A Intrammamary, Diclosan S Intrammamary and Mastilina V-S.